News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

International Wex Technologies (WXI): CTA Filing For New Clinical Study Protocol



10/19/2005 5:10:32 PM

International Wex Technologies Inc. (the "Company") is pleased to announce the filing of a Clinical Trial Application (CTA) with Health Canada for patients suffering refractory severe chronic pain where treatment with current analgesics has failed. This study will be an open-label protocol to assess the safety and therapeutic exploratory of Tectin(TM) in this target population.

Read at CCNMatthews


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES